Search research articles
Contact Us
Filters
Showing results (21-30 of 89) with videos related to
Page
of 9
Sort By:
Peptides
|
May 7, 2003
VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: a study in biopsy specimens
Rebeca Busto, Juan C Prieto, Guillermo Bodega, et al.
International Journal of Oncology
|
February 10, 2004
Luteinizing hormone-releasing hormone antagonist Cetrorelix regulates the expression of Galphas and Galphai protein subunits and adenylate cyclase activity in rat ovary, breast and pituitary
Beatriz Collado, María J Carmena, Joaquín Cortés, et al.
Peptides
|
June 5, 2007
Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model
Beatriz Collado, María J Carmena, Celia Clemente, et al.
Pharmacological Reports : PR
|
April 9, 2013
Systemic synergism between codeine and morphine in three pain models in mice
Hugo F Miranda, Viviana Noriega, Ramiro J Zepeda, et al.
Regulatory Peptides
|
August 9, 2007
Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells
Ana Valdehita, María J Carmena, Beatriz Collado, et al.
Inflammation
|
December 27, 2011
Synergism between fentanyl and tramadol in tonic inflammatory pain: the orofacial formalin test
Hugo F Miranda, Viviana Noriega, Ramiro J Zepeda, et al.
Regulatory Peptides
|
April 20, 2004
Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells
Beatriz Collado, Irene Gutiérrez-Cañas, Nieves Rodríguez-Henche, et al.
Biochimica Et Biophysica Acta
|
June 1, 2005
Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation
Beatriz Collado, María G Sánchez, Inés Díaz-Laviada, et al.
Fundamental & Clinical Pharmacology
|
August 3, 2018
Synergism between gabapentin-tramadol in experimental diabetic neuropathic pain
Hugo F Miranda, Fernando Sierralta, Nicolas Aranda, et al.
Basic & Clinical Pharmacology & Toxicology
|
June 25, 2011
Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice
Hugo F Miranda, Viviana Noriega, Loreto Olavarria, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 89) with videos related to
Sort By:
Page
of 9
Peptides
|
May 7, 2003
VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: a study in biopsy specimens
Rebeca Busto, Juan C Prieto, Guillermo Bodega, et al.
International Journal of Oncology
|
February 10, 2004
Luteinizing hormone-releasing hormone antagonist Cetrorelix regulates the expression of Galphas and Galphai protein subunits and adenylate cyclase activity in rat ovary, breast and pituitary
Beatriz Collado, María J Carmena, Joaquín Cortés, et al.
Peptides
|
June 5, 2007
Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model
Beatriz Collado, María J Carmena, Celia Clemente, et al.
Pharmacological Reports : PR
|
April 9, 2013
Systemic synergism between codeine and morphine in three pain models in mice
Hugo F Miranda, Viviana Noriega, Ramiro J Zepeda, et al.
Regulatory Peptides
|
August 9, 2007
Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells
Ana Valdehita, María J Carmena, Beatriz Collado, et al.
Inflammation
|
December 27, 2011
Synergism between fentanyl and tramadol in tonic inflammatory pain: the orofacial formalin test
Hugo F Miranda, Viviana Noriega, Ramiro J Zepeda, et al.
Regulatory Peptides
|
April 20, 2004
Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells
Beatriz Collado, Irene Gutiérrez-Cañas, Nieves Rodríguez-Henche, et al.
Biochimica Et Biophysica Acta
|
June 1, 2005
Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation
Beatriz Collado, María G Sánchez, Inés Díaz-Laviada, et al.
Fundamental & Clinical Pharmacology
|
August 3, 2018
Synergism between gabapentin-tramadol in experimental diabetic neuropathic pain
Hugo F Miranda, Fernando Sierralta, Nicolas Aranda, et al.
Basic & Clinical Pharmacology & Toxicology
|
June 25, 2011
Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice
Hugo F Miranda, Viviana Noriega, Loreto Olavarria, et al.
Page
of 9